Limited data exists on trends in prostate-specific antigen (PSA) screening in men with family history of prostate cancer (PCa).
1) to study age-stratified temporal trends in PSA screening from 2000-2018 for men with a family history of PCa and black men with family history of PCa; and 2) identify determinants associated with receipt of PSA screening in aforementioned groups.
We identified men aged ≥40 without prior history of PCa using data from National Health Institution Survey (NHIS) 2000-2018 who self-reported PSA testing in the last 12 months. Age-stratified temporal trends and weighted multivariable logistic regression analyses were assessed.
PSA screening increased for men with a family history of prostate cancer between NHIS 2000 (28.9%) and 2005 (41.9%), with stable rates for the following years. Black men with family history of PCa showed no significant change in PSA screening rates regardless of age. Controlling for socio-demographics and access to healthcare provider, younger age (40-54) and later survey years (2013-2018) were associated with a lower likelihood of PSA screening overall and for black men, but not for those with positive family history.
Data from nationally representative study of US men indicated that the annual PSA screening rates for men with a family history of PCa was higher than reported for the overall male population. We believe this represents the first study on trends and determinants of PSA screening in US men with a family history of PCa.
Urology practice. 2023 Jun 22 [Epub ahead of print]
Deepansh Dalela, Taylor Malchow, Mohit Butaney, Sami Majdalany, Nick Corsi, Ivan Rakic, Akshay Sood, Craig Rogers, Firas Abdollah
VUI Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan., Wright State Boonshoft School of Medicine, Dayton, Ohio.